[go: up one dir, main page]

AR060963A1 - Forma cristalina de fosfato diacido de 2-{etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo - Google Patents

Forma cristalina de fosfato diacido de 2-{etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo

Info

Publication number
AR060963A1
AR060963A1 ARP070102121A ARP070102121A AR060963A1 AR 060963 A1 AR060963 A1 AR 060963A1 AR P070102121 A ARP070102121 A AR P070102121A AR P070102121 A ARP070102121 A AR P070102121A AR 060963 A1 AR060963 A1 AR 060963A1
Authority
AR
Argentina
Prior art keywords
amino
quinazolin
fluorophenyl
phosphate
oxoetil
Prior art date
Application number
ARP070102121A
Other languages
English (en)
Inventor
George Joseph Sependa
Richard Storey
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36637528&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR060963(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR060963A1 publication Critical patent/AR060963A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se relaciona con un nuevo co-cristal de fosfato diácido de 2-[etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1H-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo (AZD1152) que es un inhibidor de aurora quinasa util para el tratamiento de enfermedades hiperproliferativas tal como cáncer.
ARP070102121A 2006-05-16 2007-05-16 Forma cristalina de fosfato diacido de 2-{etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo AR060963A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0609621.8A GB0609621D0 (en) 2006-05-16 2006-05-16 Novel co-crystal

Publications (1)

Publication Number Publication Date
AR060963A1 true AR060963A1 (es) 2008-07-23

Family

ID=36637528

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070102121A AR060963A1 (es) 2006-05-16 2007-05-16 Forma cristalina de fosfato diacido de 2-{etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo

Country Status (22)

Country Link
US (1) US7625910B2 (es)
EP (1) EP2027114A1 (es)
JP (1) JP2009537498A (es)
KR (1) KR20090009297A (es)
CN (1) CN101448823A (es)
AR (1) AR060963A1 (es)
AU (1) AU2007251304A1 (es)
BR (1) BRPI0712791A2 (es)
CA (1) CA2650519A1 (es)
CL (1) CL2007001388A1 (es)
EC (1) ECSP088890A (es)
GB (1) GB0609621D0 (es)
IL (1) IL194862A0 (es)
MX (1) MX2008014550A (es)
NO (1) NO20084580L (es)
RU (1) RU2008149242A (es)
SA (1) SA07280243B1 (es)
TW (1) TW200813026A (es)
UA (1) UA95108C2 (es)
UY (1) UY30351A1 (es)
WO (1) WO2007132227A1 (es)
ZA (1) ZA200809172B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2323215C2 (ru) * 2001-12-24 2008-04-27 Астразенека Аб Замещенные производные хиназолина как ингибиторы ауроракиназы
EP2251343A1 (en) * 2003-05-15 2010-11-17 Arqule, Inc. Imidazothiazoles as p38-kinase-inhibitors
CA2584368A1 (en) * 2004-10-19 2006-04-27 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
WO2007123892A2 (en) * 2006-04-17 2007-11-01 Arqule Inc. Raf inhibitors and their uses
CN102317293A (zh) * 2008-12-05 2012-01-11 艾科尔公司 Raf抑制剂及其用途
EA020526B1 (ru) * 2009-09-11 2014-11-28 Амген Инк. Применение n-(4-((3-(2-амино-4-пиримидинил)-2-пиридинил)окси)фенил)-4-(4-метил-2-тиенил)-1-фталазинамина для лечения резистентного к антимитотическому агенту рака
GB201007286D0 (en) 2010-04-30 2010-06-16 Astex Therapeutics Ltd New compounds
GB201020179D0 (en) 2010-11-29 2011-01-12 Astex Therapeutics Ltd New compounds
GB201118652D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118654D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201118675D0 (en) 2011-10-28 2011-12-14 Astex Therapeutics Ltd New compounds
GB201118656D0 (en) 2011-10-28 2011-12-07 Astex Therapeutics Ltd New compounds
GB201209609D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201209613D0 (en) 2012-05-30 2012-07-11 Astex Therapeutics Ltd New compounds
GB201307577D0 (en) 2013-04-26 2013-06-12 Astex Therapeutics Ltd New compounds
DK3046584T3 (en) * 2013-09-16 2017-10-02 Astrazeneca Ab THERAPEUTIC POLYMER NANOPARTICLES AND PROCEDURES FOR PREPARING AND USING THEREOF
RU2715236C2 (ru) 2014-03-26 2020-02-26 Астекс Терапьютикс Лтд Комбинации
JO3512B1 (ar) 2014-03-26 2020-07-05 Astex Therapeutics Ltd مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
HUE053653T2 (hu) 2014-03-26 2021-07-28 Astex Therapeutics Ltd FGFR inhibitor és IGF1R inhibitor kombinációi
JOP20200201A1 (ar) 2015-02-10 2017-06-16 Astex Therapeutics Ltd تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين
US10478494B2 (en) 2015-04-03 2019-11-19 Astex Therapeutics Ltd FGFR/PD-1 combination therapy for the treatment of cancer
ES2904513T3 (es) 2015-09-23 2022-04-05 Janssen Pharmaceutica Nv 1,4-Benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cáncer
EP3353177B1 (en) 2015-09-23 2020-06-03 Janssen Pharmaceutica NV Tricyclic heterocycles for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2323215C2 (ru) * 2001-12-24 2008-04-27 Астразенека Аб Замещенные производные хиназолина как ингибиторы ауроракиназы
PL221490B1 (pl) * 2002-12-24 2016-04-29 Astrazeneca Ab Pochodne fosfonooksychinazoliny, ich kompozycje farmaceutyczne oraz ich zastosowania

Also Published As

Publication number Publication date
SA07280243B1 (ar) 2010-12-01
BRPI0712791A2 (pt) 2012-09-04
US7625910B2 (en) 2009-12-01
ZA200809172B (en) 2009-12-30
GB0609621D0 (en) 2006-06-21
AU2007251304A1 (en) 2007-11-22
ECSP088890A (es) 2008-12-30
KR20090009297A (ko) 2009-01-22
UA95108C2 (en) 2011-07-11
CN101448823A (zh) 2009-06-03
TW200813026A (en) 2008-03-16
IL194862A0 (en) 2009-08-03
UY30351A1 (es) 2008-01-02
US20080045481A1 (en) 2008-02-21
NO20084580L (no) 2009-02-05
WO2007132227A1 (en) 2007-11-22
CL2007001388A1 (es) 2008-01-18
EP2027114A1 (en) 2009-02-25
MX2008014550A (es) 2008-11-27
JP2009537498A (ja) 2009-10-29
CA2650519A1 (en) 2007-11-22
RU2008149242A (ru) 2010-06-27

Similar Documents

Publication Publication Date Title
AR060963A1 (es) Forma cristalina de fosfato diacido de 2-{etil[3-({4-[(5-{2-[(3-fluorofenil)amino]-2-oxoetil}-1h-pirazol-3-il)amino]quinazolin-7-il}oxi)propil]amino}etilo
BR112012024117A2 (pt) inibidores de pirrolopirazina quinase
MA32551B1 (fr) Nouveaux composes utiles pour le traitement de maladies degeneratives et inflammatoires
UA107796C2 (en) Tetracyclic compound
PA8848201A1 (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes
SV2011003809A (es) Derivados de heteroarilo como inhibidores de dgat1
ATE517107T1 (de) Pyrrolopyrazinkinaseinhibitoren
PL2049502T3 (pl) 2,4-Podstawione chinazoliny jako inhibitory kinazy lipidowej
CR10343A (es) Aminotetrahidropiranos como inihibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes
NI200900032A (es) Compuestos de pirido (2, 3-d) pirimidinonay su uso como inhibidores de pi3
EP2116543A4 (en) NEW AMINOPYRIMIDINE DERIVATIVE AS PLK1 INHIBITOR
CR9947A (es) Compuestos de pirimidinil benzotiofeno
UY31065A1 (es) Heterociclos ciclicos
MX2009006481A (es) Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
MX2012013130A (es) Compuestos heterociclicos de nitrogeno utiles como inhibidores de pde10.
BR112012008147A2 (pt) compostos heteroarílicos como inibidores da quinase
EP2142868A4 (en) CONTROL METHOD FOR REFRIGERATOR
SV2009003153A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
HN2008001490A (es) Nuevo procedimiento de sintesis del ranelato de estroncio y de sus hidratos
SV2009003286A (es) Sal de potasio cristalina de analogos de lipoxina a4
BR112013033836A2 (pt) terapia de combinação
EP2140214A4 (en) Controlling process for refrigerator
GT200700105A (es) Inhibidor del factor xa
MX2009004982A (es) Derivados heterociclicos como inhibidores cetp.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal